Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience

Dosing regimens for antithymocyte globulin (ATG) and anti-CD52 antibody (alemtuzumab) for graft vs. host disease prophylaxis (GVHD) are empiric or weight-based, and do not account for individual patient factors. Recently, it has been shown that recipient peripheral blood absolute lymphocyte count (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheth, Vipul, Kennedy, Vanessa, de Lavallade, Hugues, Mclornan, Donal, Potter, Victoria, Engelhardt, Brian G., Savani, Bipin, Chinratanalab, Wichai, Goodman, Stacey, Greer, John, Kassim, Adetola, York, Sally, Kenyon, Michelle, Gandhi, Shreyans, Kulasekararaj, Austin, Marsh, Judith, Mufti, Ghulam, Pagliuca, Antonio, Jagasia, Madan, Raj, Kavita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636242/
https://www.ncbi.nlm.nih.gov/pubmed/31355140
http://dx.doi.org/10.3389/fonc.2019.00623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636242/
https://www.ncbi.nlm.nih.gov/pubmed/31355140
http://dx.doi.org/10.3389/fonc.2019.00623

Ejemplares similares